The Meds Changing the Game: GLP-1s Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDAapproved injectables that curb appetite, improve insulin sensitivity, and support sustainable weight loss
Gke R, Fehmann HC, Linn T et al (1993) Exendin-4 is a high potency agonist and truncated exendin-(939)-amide an antagonist at the glucagon-like peptide 1-(736)-amide receptor of insulin-secreting beta-cells
Novo Nordisk, maker of the brands, will effectively lose its market exclusivity on those drugs in Canada in January, opening the door to generic versions
Looking back at my 'before' photos, where I was in a tank top and shorts, and comparing them to now, comfortably in my long-sleeved top and leggings, feels surreal
They represent a patient population actively experiencing symptoms and looking for answers answers that, in many cases, their GP or prescribing physician may not be equipped to give